Free Trial
NASDAQ:QNTM

Quantum Biopharma 3/28/2025 Earnings Report

Quantum Biopharma logo
$11.55 -0.67 (-5.48%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$11.73 +0.18 (+1.56%)
As of 05/23/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Quantum Biopharma EPS Results

Actual EPS
-$2.89
Consensus EPS
-$0.80
Beat/Miss
Missed by -$2.09
One Year Ago EPS
N/A

Quantum Biopharma Revenue Results

Actual Revenue
N/A
Expected Revenue
$0.92 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

Quantum Biopharma Announcement Details

Quarter
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Quantum Biopharma's next earnings date is estimated for Wednesday, August 13, 2025, based on past reporting schedules.

Conference Call Resources

Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Quantum Biopharma? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Quantum Biopharma and other key companies, straight to your email.

About Quantum Biopharma

Quantum Biopharma (NASDAQ:QNTM) is a clinical-stage biopharmaceutical company focused on developing novel therapeutics for neurodegenerative diseases, including Lucid-MS, a first-in-class small molecule drug candidate designed to promote remyelination in patients with Multiple Sclerosis (MS).

View Quantum Biopharma Profile

More Earnings Resources from MarketBeat